Become a member

Translational Biology

Mission

Mission

The mission of the Translational Biology Section is to advance the care of critically ill patients by discovering and advancing new and emerging therapies towards clinical testing. The Section will enable its members to discover novel pathways, biomarkers and interventions in critical illness that can then be tested in clinical trials to discover new therapies for our patients.

News June 2026

Members of the Translational Biology Section represented ESICM at the Wiggers-Bernard Conference 2026: Advancing Quality in Sepsis Research, held in Vienna, Austria, from 26 to 28 March 2026.

We are pleased to announce that Dr Denise Battaglini has been appointed Chair-Elect of the Translational Biology Section.

In collaboration with the other co-organisers, the Section is currently planning the LIVES Physiology and Translational Biology Conference, which will be held in Athens in 2027.

Specific aims and objectives of Section 

  • To enhance the profile of basic/translational research within ESICM by providing opportunities for collaboration, education and training to members and trainees within ESICM
  • Develop a Registry of Basic/Translational research groups and their research capabilities, which can be made available as a resource to Section members for networking and collaboration purposes.
  • Identify key knowledge gaps that exists within basic/translational research across the ESICM membership and develop strategies to address these gaps.
  • Increase chances for H2020 funding by facilitating the development of transnational research networks focused on acute organ injury, ARDS and sepsis.
  • To establish ESICM endorsed reference papers on state-of-the-art disease models, focused on acute organ injury, ARDS and sepsis.
  • To provide a platform to engage with the wider ESICM membership regarding Basic/Translational research. A key approach here will be collaborating with other Sections to embed talks on the Basic/Translational science underpinning clinical advances into lecture sessions at LIVES conferences,
  • Partner with Intensive Care Medicine Experimental as the platform journal for preclinical critical care research to develop it into the leading journal focused on basic/translational research in critical care
  • Act as the ESICM partner for other external organisations to provide additional platforms for presentation of preclinical/translational research that focuses on emerging researchers.
  • Partner with the NEXT trainee group to examine ways to provide enhanced training opportunities using our network of laboratories across Europe.

The last TransBio Section meeting took place online on 25 March 2026.

Minutes March 2026

Minutes October 2025

Minutes September 2025

Minutes September 2023

Minutes May 2023

Minutes October 2022

>Access TransBio Resources

Board

Position Firstname Lastname City Country
Chair Miklos Lipcsey Uppsala Sweden
Research Committee Representative Gaetano Perchiazzi Uppsala Sweden
Social Media and Digital Content Committee Representative Burcin Halacli Ankara Turkey
Academy Sub-Committee Representative Luis Morales Barcelona Spain
Academy Sub-Committee NEXT Representative Marta Camprubi Rimblas Sabadell Spain

Members